Anthony M. Manning
CIK 1716468 · Chief Scientific Officer · last filed 2026-05-22
Anthony M. Manning is a Chief Scientific Officer who has filed 52 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for GLUE, was dated May 22, 2026. Across all open-market trades the lifetime net is −$6.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $673.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$673.2K
3
52
-$6.52M
Holdings By Company
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | GLUE | Mixed | — | -$138.5K | EDGAR |
| 2025-06-16 | GLUE | Grant (A) | — | $0 | EDGAR |
| 2024-07-16 | PTN | Grant (A) | +12,000 | $0 | EDGAR |
| 2024-06-13 | GLUE | Grant (A) | — | $0 | EDGAR |
| 2023-07-26 | GLUE | Grant (A) | — | $0 | EDGAR |
| 2023-06-22 | PTN | Grant (A) | +10,000 | $0 | EDGAR |
| 2022-06-24 | PTN | Grant (A) | +73,000 | $0 | EDGAR |
| 2021-06-24 | PTN | Grant (A) | +77,000 | $0 | EDGAR |
| 2020-10-01 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Disp (D) | −12,778 | $0 | EDGAR |
| 2020-08-13 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Sell (S) | −403 | -$11.8K | EDGAR |